What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?

What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?

VJHemOnc

3 years
970 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
John Gribben, MD, DSc, FRCPath, FMed Sci of Barts Cancer Institute, London, UK discusses the place of allogeneic stem cell transplantation in chronic lymphocytic leukemia (CLL) at the 2016 International Workshop of the German CLL Study Group (GCLLSG) in Cologne, Germany. Prof. Gribben points out that allogeneic stem cell transplantation is the only curative treatment available in CLL. However, only a small population of patients can receive a transplant due to age and it is associated with morbidity (specifically from graft-versus-host-disease) and mortality. When the choice was between a transplant or having no effective salvage therapy, the decision was more clear-cut. With the advent of new drugs with high response rates and good duration of response as well as toxicity profiles, it is becoming less clear where an allogeneic stem cell transplant fits into the management of CLL. There are guidelines available but there is no clear consensus and no sufficient data on this question. As Prof. Gribben explains, it is important not to miss the window in which a transplant would be useful. Finally, Prof. discusses how with idelalisib, ibrutinib and venetoclax now available to salvage the high-risk patients, the transplant is again moved further back in the treatment of CLL.
Up Next Autoplay
Novel Prostate Cancer Gene Fusion
Novel Prostate Cancer Gene Fusion
Category: Prostate Cancer
1 Views
Henry Ford Health System 58 minutes
Trends in Breast Cancer Death Rates
Trends in Breast Cancer Death Rates
Category: Breast Cancer
0 Views
Cancer-News 1 hour
Breast Cancer Trends in U.S.
Breast Cancer Trends in U.S.
Category: Breast Cancer
0 Views
Cancer-News 1 hour
What Happens When You Have An ATRX Deletion?
What Happens When You Have An ATRX Deletion?
Category: Kidney Cancer
0 Views
Mount Sinai Health System 1 hour
Neuroblastoma in Older Children May Respond to Tazemetostat
Neuroblastoma in Older Children May Respond to Tazemetostat
Category: Kidney Cancer
1 Views
Mount Sinai Health System 2 hours
Lower Costs in Breast Cancer: How This Affects Treatment
Lower Costs in Breast Cancer: How This Affects Treatment
Category: Breast Cancer
0 Views
ONeal Comprehensive Cancer Center 3 hours
When Can This Be Used In Clinical Practice?
When Can This Be Used In Clinical Practice?
Category: Other
2 Views
Baylor College of Medicine 2 days
New Testing for Thyroid Cancer
New Testing for Thyroid Cancer
Category: Other
4 Views
Baylor College of Medicine 2 days
Lower Costs for Patients in Metastatic Breast Cancer
Lower Costs for Patients in Metastatic Breast Cancer
Category: Breast Cancer
16 Views
ONeal Comprehensive Cancer Center 4 days
New Technology to Streamline Drug Discovery
New Technology to Streamline Drug Discovery
Category: Other
5 Views
Cancer-News 5 days